Delivery Order SPE2DB22D3301-SPE2DB24FZ3RL
Award Date
8/28/24
Potential Completion Date
9/19/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $6,168.26 and has a completion date of February 24, 2025. It is for the delivery of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a larger...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,451.57, is for the delivery of HEMLIBRA 150 MG/ML VIAL and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a medication, with a firm fixed price of $24,673.08 and a period of performance ending on July 18, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp is the prime contractor and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of the pharmaceutical product HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $23,330.40 and a completion date of October 9, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is part of the company's extensive federal...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,336.54 firm fixed-price delivery order contract is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,673.08 firm fixed-price delivery order is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 29, 2025 and was awarded on April 8, 2025. This contract award is a part of a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $16,704.72 firm-fixed-price delivery order is for the supply of Hemlibra, a prescription medication, with a completion date of September 10, 2024. This award does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite-delivery contracts (IDCs) with DLA and other federal agencies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of Heparin Sodium 10,000 Unit/mL Vials. The contract has a ceiling value of $1,114.82 and is a firm fixed price, delivery order contract with an ultimate completion date of August 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide essential medical commodities to support military treatment...
This federal contract award is for the delivery of Heparin, a pharmaceutical anticoagulant, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,922.55, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 9, 2024. The contract is a Firm Fixed Price Delivery Order with a completion date of October 10, 2024. This contract is not set aside for any specific business designation. As a key supplier of pharmaceutical products and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of 1,000 unit/500 ML-NS 500 ML heparin, a critical medical supply, with a potential value of $2,129.71 and a completion date of February 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...